Skip to main content
OLYMPUS CORPORATION logo

OLYMPUS CORPORATION — Investor Relations & Filings

Ticker · 7733 ISIN · JP3201200007 LEI · 5299000Y52IFDI1I2A21 T Manufacturing
Open in API
Filings indexed 102 across all filing types
Latest filing 2025-08-07 Transaction in Own Shar…
Country JP Japan
Listing T 7733

About OLYMPUS CORPORATION

https://www.olympus-global.com/

Olympus Corporation is a global medical technology (medtech) company focused on making people's lives healthier, safer, and more fulfilling. The company develops, manufactures, and commercializes innovative solutions for the medical and healthcare sectors, specializing in early detection, diagnosis, and minimally invasive treatment. Its core product portfolio includes medical endoscopes, endotherapy devices, and therapeutic energy devices. These technologies are applied across various medical specialties such as gastroenterology, urology, gynecology, and general surgery. Leveraging its expertise in optical and digital precision technology, Olympus provides comprehensive solutions that also encompass advanced video imaging systems and system integration services for healthcare facilities.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is a 'Report on Status of Purchase of Treasury Shares' (自己株券買付状況報告書) filed under Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act of Japan. It details the company's (Olympus Corporation) share buyback activities, including the number of shares acquired, the total cost, and the progress against the board-authorized repurchase plan for the period of July 2025. This document specifically reports on the company's transactions in its own shares, which aligns perfectly with the definition for the 'Transaction in Own Shares' (POS) category.
2025-08-07 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and explicitly cites the legal basis as "金融商品取引法第24条の６第１項" (Financial Instruments and Exchange Act Article 24-6, Paragraph 1). This type of filing in Japan details the company's activity regarding the repurchase or disposal of its own shares during a specific reporting period (June 1, 2025, to June 30, 2025). This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). It is a report itself, not an announcement of a report (RPA).
2025-07-07 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and explicitly states its legal basis as "金融商品取引法第24条の６第１項" (Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act). This type of filing in Japan details the company's treasury stock transactions (buybacks and disposals) over a specific reporting period (May 1, 2025, to May 31, 2025). This directly corresponds to reporting on share transactions, specifically share repurchases or issuance, which aligns best with the 'Transaction in Own Shares' category (POS). Although it involves capital structure changes, POS is more specific to treasury stock movements than 'Share Issue/Capital Change' (SHA).
2025-07-07 Japanese
訂正発行登録書
Capital/Financing Update Classification · 95% confidence The document is titled "訂正発行登録書" (Correction Registration Statement) and is submitted to the Kanto Local Finance Bureau Director ("関東財務局長"). It explicitly mentions the type of security being registered as "社債" (Corporate Bonds) and refers to the original filing date of the Registration Statement. The 'Reason for Submission' section states that this correction is being filed in conjunction with submitting Extraordinary Reports (臨時報告書) under Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act. This document is a formal regulatory filing related to the registration of securities (debt issuance). While it relates to capital/financing (CAP), the specific nature of correcting a prior registration statement for securities issuance points towards a general regulatory filing category, or potentially a specific financing update if a more precise code existed. Given the options, this is a formal regulatory filing concerning securities issuance registration, which is best categorized as a general regulatory filing (RNS) or potentially related to Capital/Financing Update (CAP). Since it is a formal correction to a registration statement for debt issuance, and not a general announcement, RNS is the most appropriate fallback for a specific Japanese regulatory filing not explicitly listed, although it strongly relates to 'CAP'. However, looking closely at the definitions, 'CAP' is for 'Updates on company fundraising, financing activities, or capital structure changes.' A correction to a shelf registration for bonds fits this well. Given the highly specific nature of the document (a correction to a shelf registration statement for corporate bonds), and the lack of a specific 'Shelf Registration Correction' code, I will evaluate between CAP and RNS. Since it directly concerns the issuance framework (financing), CAP is a strong candidate. However, 'RNS' is defined as 'General regulatory announcements and fallback category for miscellaneous filings that do not neatly fit into other specific categories.' Since this is a specific amendment to a registration document, and not a general announcement, and there is no 'Registration Statement' code, RNS is the safest classification for a specific, non-standard regulatory document type in this context, especially as it is a correction filing. Revisiting the definitions: 'CAP' is for updates on fundraising/financing activities. This is a correction to the framework under which financing (issuance of bonds) can occur. I will classify this as 'CAP' as it directly pertains to the mechanism of future financing/capital structure, which is more specific than the general 'RNS' fallback. The confidence is high due to the clear regulatory context.
2025-06-27 Japanese
臨時報告書
Remuneration Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director. The content details the resolution to grant stock compensation units (PSU and RSU) to directors, executive officers, and employees. This type of filing, which reports on specific corporate actions like executive compensation grants, often falls under specific disclosure rules in Japan. Since the core subject is the granting of stock compensation (remuneration/incentives) to management and employees, it strongly aligns with the definition of Remuneration Information (DEF 14A in the US context, though this is a Japanese filing). However, given the provided codes, the closest fit for detailed compensation/incentive plans and grants, especially when involving stock, is often related to governance or remuneration disclosures. Since the document explicitly details the grant of stock compensation (PSU/RSU) to directors and executives, it is most accurately classified as Remuneration Information. If this were a US filing, it would be a proxy statement section or an 8-K related to executive compensation. Among the provided codes, DEF 14A (Remuneration Information) is the most appropriate category for detailed executive compensation decisions, even though the filing format is a Japanese 'Rinji Hokokusho' (Extraordinary Report).
2025-06-27 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report) and explicitly states in Section 1 that it is being filed pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act, following resolutions made at the Annual General Meeting (AGM) held on June 26, 2025. Section 2 details the resolutions, specifically the election of 11 directors, and provides the vote counts (For, Against, Abstain) and results for each director. This structure—reporting the outcome of shareholder votes on board appointments following a general meeting—is characteristic of a Declaration of Voting Results & Voting Rights Announcement (DVA). Although it relates to the AGM, the primary content is the voting outcome report, not the AGM presentation materials (AGM-R) or the proxy solicitation (PSI). The document length is relatively short, but its purpose is definitive reporting of results, not just announcing a report's availability (RPA).
2025-06-27 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.